全外显子组测序分析支持维生素D代谢在缺血性卒中中的作用
研究利用英国生物银行152058名参与者的全外显子组测序数据(含1777例缺血性卒中),进行罕见变异单变异分析和基因水平分析,发现CYP2R1罕见变异与缺血性卒中风险显著关联,并在MEGASTROKE、VISP试验和神经影像数据中得到验证,支持维生素D代谢通路在缺血性卒中发生中的作用。
要点
- CYP2R1罕见变异与缺血性卒中风险显著关联(P=2.6×10-6),超过Bonferroni校正阈值。
- CYP2R1与缺血性卒中风险的关联在MEGASTROKE中验证(P=0.003)。
- CYP2R1与VISP试验中卒中复发(P=0.001)及英国生物银行神经影像特征相关。
核心结论
- CYP2R1在维生素D代谢中起重要作用,现有观察性证据提示维生素D水平与脑血管病相关,本研究结果支持该通路在缺血性卒中发生中的作用。
研究设计与样本
- 基于英国生物银行152058名参与者的全外显子组测序数据(含1777例缺血性卒中)进行外显子组范围研究。
- 对罕见变异进行单变异分析,并对功能缺失和有害错义罕见变异进行基因水平分析。
- 通过MEGASTROKE全基因组关联研究(67162例缺血性卒中和454450例对照)的汇总统计进行基因水平验证。
- 通过VISP试验(维生素干预卒中预防)中1706例缺血性卒中幸存者(含142例复发性缺血性卒中)的个体水平数据进行基因水平验证。
- 利用英国生物银行42310名有磁共振成像数据参与者的汇总数据进行脑血管病相关神经影像表型的基因水平验证。
主要发现
- 单变异关联分析中,所评估变异均未达到全基因组显著性水平(P<5×10-8)。
- 基因水平分析显示CYP2R1罕见遗传变异与缺血性卒中风险显著关联(P=2.6×10-6),超过16074次检验的Bonferroni校正阈值(P<3.1×10-6)。
- 验证分析表明CYP2R1与MEGASTROKE中缺血性卒中风险相关(基因水平检验,P=0.003)。
- CYP2R1与VISP试验中缺血性卒中复发相关(基因水平检验,P=0.001)。
- CYP2R1与英国生物银行神经影像研究中的神经影像特征(白质高信号、平均弥散率、各向异性分数)相关(所有基因水平检验,P<0.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ischemic stroke (IS) is a highly heritable trait, and genome-wide association studies have identified several commonly occurring susceptibility risk loci for this condition. However, there are limited data on the contribution of rare genetic variation to IS. METHODS: We conducted an exome-wide study using whole-exome sequencing data from 152 058 UK Biobank participants, including 1777 IS cases. We performed single-variant analyses for rare variants and gene-based analyses for loss-of-function and deleterious missense rare variants. We validated these results through (1) gene-based testing using summary statistics from MEGASTROKE-a genome-wide association study of IS that included 67 162 IS cases and 454 450 controls, (2) gene-based testing using individual-level data from 1706 IS survivors, including 142 recurrent IS cases, enrolled in the VISP trial (Vitamin Intervention for Stroke Prevention); and (3) gene-based testing against neuroimaging phenotypes related to cerebrovascular disease using summary-level data from 42 310 UK Biobank participants with available magnetic resonance imaging data. RESULTS: In single-variant association analyses, none of the evaluated variants were associated with IS at genome-wide significance levels (P<5×10-8). In the gene-based analysis focused on loss-of-function and deleterious missense variants, rare genetic variation at CYP2R1 was significantly associated with IS risk (P=2.6×10-6), exceeding the Bonferroni-corrected threshold for 16 074 tests (P<3.1×10-6). Validations analyses indicated that CYP2R1 was associated with IS risk in MEGASTROKE (gene-based test, P=0.003), with IS recurrence in the VISP trial (gene-based test, P=0.001) and with neuroimaging traits (white matter hyperintensity, mean diffusivity, and fractional anisotropy) in the UK Biobank neuroimaging study (all gene-based tests, P<0.05). CONCLUSIONS: Because CYP2R1 plays an important role in vitamin D metabolism and existing observational evidence suggests an association between vitamin D levels and cerebrovascular disease, our results support a role of this pathway in the occurrence of IS.
引用
- Xie Y, Acosta JN, Ye Y, et al. Whole-Exome Sequencing Analyses Support a Role of Vitamin D Metabolism in Ischemic Stroke. Stroke. 2023. PMID: 36762557. doi:10.1161/STROKEAHA.122.040883
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。